Download started
OkReferences
1.
McIntyre, RS ∙ Berk, M ∙ Brietzke, E ∙ et al.
Bipolar disorders
Lancet. 2020; 396:1841-1856
2.
Oliva, V ∙ Fico, G ∙ De Prisco, M ∙ et al.
Bipolar disorders: an update on critical aspects
Lancet Reg Health Eur. 2024; 48, 101135
3.
Singh, B ∙ Yocum, AK ∙ Strawbridge, R ∙ et al.
Patterns of pharmacotherapy for bipolar disorder: a GBC survey
Bipolar Disord. 2024; 26:22-32
4.
Goetzel, RZ ∙ Hawkins, K ∙ Ozminkowski, RJ ∙ et al.
The health and productivity cost burden of the “top 10” physical and mental health conditions affecting six large U.S. employers in 1999
J Occup Environ Med. 2003; 45:5-14
5.
Mavranezouli, I ∙ Lokkerbol, J
A systematic review and critical appraisal of economic evaluations of pharmacological interventions for people with bipolar disorder
PharmacoEconomics. 2017; 35:271-296
6.
Bessonova, L ∙ Ogden, K ∙ Doane, MJ ∙ et al.
The economic burden of bipolar disorder in the United States: a systematic literature review
Clinicoecon Outcomes Res. 2020; 12:481-497
7.
Simon, J ∙ Pari, AAA ∙ Wolstenholme, J ∙ et al.
The costs of bipolar disorder in the United Kingdom
Brain Behav. 2021; 11, e2351
8.
Dembek, C ∙ Mackie, D ∙ Modi, K ∙ et al.
The economic and humanistic burden of bipolar disorder in adults in the United States
Ann Gen Psychiatry. 2023; 22:13
9.
Merikangas, KR ∙ Jin, R ∙ He, JP ∙ et al.
Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative
Arch Gen Psychiatry. 2011; 68:241-251
10.
Nierenberg, AA ∙ Agustini, B ∙ Köhler-Forsberg, O ∙ et al.
Diagnosis and treatment of bipolar disorder: a review
JAMA. 2023; 330:1370-1380
11.
He, H ∙ Hu, C ∙ Ren, Z ∙ et al.
Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: results from the Global Burden of Disease Study 2017
J Psychiatr Res. 2020; 125:96-105
12.
Post, RM ∙ Altshuler, LL ∙ Kupka, R ∙ et al.
More childhood onset bipolar disorder in the United States than Canada or Europe: implications for treatment and prevention
Neurosci Biobehav Rev. 2017; 74:204-213
13.
Semahegn, A ∙ Torpey, K ∙ Manu, A ∙ et al.
Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis
Syst Rev. 2020; 9:17
14.
Chan, JKN ∙ Tong, CHY ∙ Wong, CSM ∙ et al.
Life expectancy and years of potential life lost in bipolar disorder: systematic review and meta-analysis
Br J Psychiatry. 2022; 221:567-576
15.
Kessing, LV ∙ Vradi, E ∙ McIntyre, RS ∙ et al.
Causes of decreased life expectancy over the life span in bipolar disorder
J Affect Disord. 2015; 180:142-147
16.
Foroughi, M ∙ Medina Inojosa, JR ∙ Lopez-Jimenez, F ∙ et al.
Association of bipolar disorder with major adverse cardiovascular events: a population-based historical cohort study
Psychosom Med. 2022; 84:97-103
17.
Miller, JN ∙ Black, DW
Bipolar disorder and suicide: a review
Curr Psychiatry Rep. 2020; 22:6
18.
Dev, DA ∙ Le, GH ∙ Kwan, ATH ∙ et al.
Comparing suicide completion rates in bipolar I versus bipolar II disorder: a systematic review and meta-analysis
J Affect Disord. 2024; 361:480-488
19.
Khoso, AB ∙ Noureen, A ∙ Un Nisa, Z ∙ et al.
Prevalence of suicidal ideation and suicide attempts in individuals with psychosis and bipolar disorder in South Asia: systematic review and meta-analysis
BJPsych Open. 2023; 9:e179
20.
Plans, L ∙ Barrot, C ∙ Nieto, E ∙ et al.
Association between completed suicide and bipolar disorder: a systematic review of the literature
J Affect Disord. 2019; 242:111-122
21.
Schaffer, A ∙ Isometsä, ET ∙ Azorin, JM ∙ et al.
A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder
Aust N Z J Psychiatry. 2015; 49:1006-1020
22.
Paljärvi, T ∙ Herttua, K ∙ Taipale, H ∙ et al.
Cause-specific excess mortality after first diagnosis of bipolar disorder: population-based cohort study
BMJ Ment Health. 2023; 26, e300700
23.
Bartoli, F ∙ Bassetti, C ∙ Gazzola, M ∙ et al.
Prevalence and correlates of manic/hypomanic and depressive predominant polarity in bipolar disorder: systematic review and meta-analysis
BJPsych Open. 2024; 10:e100
24.
Manchia, M ∙ Miola, A ∙ Tondo, L ∙ et al.
Unipolar mania: prevalence and patient characteristics
Acta Psychiatr Scand. 2025; 151:680-688
25.
Alloy, LB ∙ Urošević, S ∙ Abramson, LY ∙ et al.
Progression along the bipolar spectrum: a longitudinal study of predictors of conversion from bipolar spectrum conditions to bipolar I and II disorders
J Abnorm Psychol. 2012; 121:16-27
26.
Yatham, LN ∙ Chakrabarty, T ∙ Bond, DJ ∙ et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations
Bipolar Disord. 2021; 23:767-788
27.
Miola, A ∙ Fountoulakis, KN ∙ Baldessarini, RJ ∙ et al.
Prevalence and outcomes of rapid cycling bipolar disorder: mixed method systematic meta-review
J Psychiatr Res. 2023; 164:404-415
28.
Ratheesh, A ∙ Davey, C ∙ Hetrick, S ∙ et al.
A systematic review and meta-analysis of prospective transition from major depression to bipolar disorder
Acta Psychiatr Scand. 2017; 135:273-284
29.
Scott, J ∙ Graham, A ∙ Yung, A ∙ et al.
A systematic review and meta-analysis of delayed help-seeking, delayed diagnosis and duration of untreated illness in bipolar disorders
Acta Psychiatr Scand. 2022; 146:389-405
30.
Dunayevich, E ∙ Keck, Jr, PE
Prevalence and description of psychotic features in bipolar mania
Curr Psychiatry Rep. 2000; 2:286-290
31.
Nusslock, R ∙ Frank, E
Subthreshold bipolarity: diagnostic issues and challenges
Bipolar Disord. 2011; 13:587-603
32.
Torales, J ∙ González, I ∙ Barrios, I ∙ et al.
Manic episodes due to medical illnesses: a literature review
J Nerv Ment Dis. 2018; 206:733-738
33.
Lichtenstein, P ∙ Yip, BH ∙ Björk, C ∙ et al.
Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study
Lancet. 2009; 373:234-239
34.
O'Connell, KS ∙ Koromina, M ∙ van der Veen, T ∙ et al.
Genomics yields biological and phenotypic insights into bipolar disorder
Nature. 2025; 639:968-975
35.
Aas, M ∙ Bellivier, F ∙ Bettella, F ∙ et al.
Childhood maltreatment and polygenic risk in bipolar disorders
Bipolar Disord. 2020; 22:174-181
36.
Fürtjes, AE ∙ Coleman, JRI ∙ Tyrrell, J ∙ et al.
Associations and limited shared genetic aetiology between bipolar disorder and cardiometabolic traits in the UK Biobank
Psychol Med. 2021; 52:1-10
37.
Meijsen, J ∙ Hu, K ∙ Krebs, MD ∙ et al.
Quantifying the relative importance of genetics and environment on the comorbidity between mental and cardiometabolic disorders using 17 million Scandinavians
Nat Commun. 2024; 15, 5064
38.
O'Connell, KS ∙ Coombes, BJ
Genetic contributions to bipolar disorder: current status and future directions
Psychol Med. 2021; 51:2156-2167
39.
Kato, T
Bipolar disorder: from pathophysiology to treatment
Juntendo Iji Zasshi. 2021; 68:17-24
40.
Rowland, T ∙ Perry, BI ∙ Upthegrove, R ∙ et al.
Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses
Br J Psychiatry. 2018; 213:514-525
41.
Scaini, G ∙ Andrews, T ∙ Lima, CNC ∙ et al.
Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder
Mitochondrion. 2021; 57:23-36
42.
Bodenstein, DF ∙ Kim, HK ∙ Brown, NC ∙ et al.
Mitochondrial DNA content and oxidation in bipolar disorder and its role across brain regions
NPJ Schizophr. 2019; 5:21
43.
Meloni, A ∙ Paribello, P ∙ Pinna, M ∙ et al.
Mitochondrial DNA copy number is significantly increased in bipolar disorder patients and is correlated with long-term lithium treatment
Eur Neuropsychopharmacol. 2025; 91:37-44
44.
Nishioka, M ∙ Takayama, J ∙ Sakai, N ∙ et al.
Deep exome sequencing identifies enrichment of deleterious mosaic variants in neurodevelopmental disorder genes and mitochondrial tRNA regions in bipolar disorder
Mol Psychiatry. 2023; 28:4294-4306
45.
Giménez-Palomo, A ∙ Andreu, H ∙ de Juan, O ∙ et al.
Mitochondrial dysfunction as a biomarker of illness state in bipolar disorder: a critical review
Brain Sci. 2024; 14, 1199
46.
McCarthy, MJ ∙ Gottlieb, JF ∙ Gonzalez, R ∙ et al.
Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: a critical multi-disciplinary literature review and agenda for future research from the ISBD task force on chronobiology
Bipolar Disord. 2022; 24:232-263
47.
Frye, MA ∙ Coombes, BJ ∙ McElroy, SL ∙ et al.
Association of cytomegalovirus and toxoplasma gondii antibody titers with bipolar disorder
JAMA Psychiatry. 2019; 76:1285-1293
48.
Tanaka, T ∙ Matsuda, T ∙ Hayes, LN ∙ et al.
Infection and inflammation in schizophrenia and bipolar disorder
Neurosci Res. 2017; 115:59-63
49.
Munkholm, K ∙ Jacoby, AS ∙ Lenskjold, T ∙ et al.
Leukocytes in peripheral blood in patients with bipolar disorder - trait and state alterations and association with levels of cytokines and C-reactive protein
Psychiatry Res. 2018; 261:383-390
50.
Chen, Z ∙ Huang, Y ∙ Wang, B ∙ et al.
T cells: an emerging cast of roles in bipolar disorder
Transl Psychiatry. 2023; 13:153
51.
Pereira, AC ∙ Oliveira, J ∙ Silva, S ∙ et al.
Inflammation in bipolar disorder (BD): identification of new therapeutic targets
Pharmacol Res. 2021; 163, 105325
52.
Cuellar-Barboza, AB ∙ Cabello-Arreola, A ∙ Winham, SJ ∙ et al.
Body mass index and blood pressure in bipolar patients: target cardiometabolic markers for clinical practice
J Affect Disord. 2021; 282:637-643
53.
Barbosa, IG ∙ Rocha, NP ∙ Vieira, EL ∙ et al.
Decreased percentage of CD4+ lymphocytes expressing chemokine receptors in bipolar disorder
Acta Neuropsychiatr. 2019; 31:246-251
54.
Hibar, DP ∙ Westlye, LT ∙ Doan, NT ∙ et al.
Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group
Mol Psychiatry. 2018; 23:932-942
55.
Sun, YR ∙ Herrmann, N ∙ Scott, CJM ∙ et al.
Global grey matter volume in adult bipolar patients with and without lithium treatment: a meta-analysis
J Affect Disord. 2018; 225:599-606
56.
Favre, P ∙ Pauling, M ∙ Stout, J ∙ et al., the ENIGMA Bipolar Disorder Working Group
Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals
Neuropsychopharmacology. 2019; 44:2285-2293
57.
Damgaard, V ∙ Fortea, L ∙ Schandorff, JM ∙ et al.
Multivariate patterns among multimodal neuroimaging and clinical, cognitive, and daily functioning characteristics in bipolar disorder
Neuropsychopharmacology. 2025; 50:976-982
58.
Kjærstad, HL ∙ de Siqueira Rotenberg, L ∙ Macoveanu, J ∙ et al.
Stable neural underpinnings of emotional cognition subgroups in patients newly diagnosed with bipolar disorder: a prospective fMRI study
Bipolar Disord. 2024; 26:556-569
59.
Mesbah, R ∙ Koenders, MA ∙ van der Wee, NJA ∙ et al.
Association between the fronto-limbic network and cognitive and emotional functioning in individuals with bipolar disorder: a systematic review and meta-analysis
JAMA Psychiatry. 2023; 80:432-440
60.
Krystal, S ∙ Gracia, L ∙ Piguet, C ∙ et al.
Functional connectivity of the amygdala subnuclei in various mood states of bipolar disorder
Mol Psychiatry. 2024; 29:3344-3355
61.
Schumer, MC ∙ Bertocci, MA ∙ Aslam, HA ∙ et al.
Patterns of neural network functional connectivity associated with mania/hypomania and depression risk in 3 independent young adult samples
JAMA Psychiatry. 2024; 81:167-177
62.
Jauhar, S ∙ Nour, MM ∙ Veronese, M ∙ et al.
A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia
JAMA Psychiatry. 2017; 74:1206-1213
63.
Bi, B ∙ Che, D ∙ Bai, Y
Neural network of bipolar disorder: toward integration of neuroimaging and neurocircuit-based treatment strategies
Transl Psychiatry. 2022; 12:143
64.
Amanollahi, M ∙ Jameie, M ∙ Looha, MA ∙ et al.
Machine learning applied to the prediction of relapse, hospitalization, and suicide in bipolar disorder using neuroimaging and clinical data: a systematic review
J Affect Disord. 2024; 361:778-797
65.
Claude, LA ∙ Houenou, J ∙ Duchesnay, E ∙ et al.
Will machine learning applied to neuroimaging in bipolar disorder help the clinician? A critical review and methodological suggestions
Bipolar Disord. 2020; 22:334-355
66.
Keramatian, K ∙ Chithra, NK ∙ Yatham, LN
The CANMAT and ISBD guidelines for the treatment of bipolar disorder: summary and a 2023 update of evidence
Focus Am Psychiatr Publ. 2023; 21:344-353
67.
Lin, SK ∙ Yang, SY ∙ Park, SC ∙ et al.
Prescription patterns for bipolar disorder in Asian countries: findings from research on Asian prescription pattern-bipolar disorder
Clin Psychopharmacol Neurosci. 2022; 20:61-69
68.
Tajika, A ∙ Hori, H ∙ Iga, JI ∙ et al.
Mood stabilizers and antipsychotics for acute mania: systematic review and meta-analysis of augmentation therapy vs monotherapy from the perspective of time to the onset of treatment effects
Int J Neuropsychopharmacol. 2022; 25:839-852
69.
Torres, R ∙ Czeisler, EL ∙ Chadwick, SR ∙ et al.
Efficacy and safety of iloperidone in bipolar mania: a double-blind, placebo-controlled study
J Clin Psychiatry. 2024; 85, 23m14966
70.
Monahan, C ∙ McCoy, L ∙ Powell, J ∙ et al.
Olanzapine/samidorphan: new drug approved for treating bipolar I disorder and schizophrenia
Ann Pharmacother. 2022; 56:1049-1057
71.
Yildiz, A ∙ Siafis, S ∙ Mavridis, D ∙ et al.
Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis
Lancet Psychiatry. 2023; 10:693-705
72.
Singh, B
Lithium for depression-related hospitalisation in bipolar disorder
Lancet Psychiatry. 2025; 12:165-166
73.
Park, JH ∙ Nuñez, NA ∙ Gardea-Resendez, M ∙ et al.
Short term second-generation antidepressant monotherapy in acute depressive episodes of bipolar ii disorder: a systematic review and meta-analysis
Psychopharmacol Bull. 2022; 52:45-72
74.
Chen, YB ∙ Liang, CS ∙ Wang, LJ ∙ et al.
Comparative effectiveness of valproic acid in different serum concentrations for maintenance treatment of bipolar disorder: a retrospective cohort study using target trial emulation framework
EClinicalMedicine. 2022; 54, 101678
75.
Medicines and Healthcare products Regulatory Agency
Valproate: review of safety data and expert advice on management of risks
https://assets.publishing.service.gov.uk/media/65660310312f400013e5d508/Valproate-report-review-and-expert-advice.pdf
Date: November, 2023
Date accessed: January 15, 2025
76.
Kong, L ∙ Wang, H ∙ Yan, N ∙ et al.
Effect of antipsychotics and mood stabilisers on metabolism in bipolar disorder: a network meta-analysis of randomised-controlled trials
EClinicalMedicine. 2024; 71, 102581
77.
Li, S ∙ Xu, C ∙ Hu, S ∙ et al.
Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis
Eur Psychiatry. 2024; 67:e29
78.
Kendall, T ∙ Morriss, R ∙ Mayo-Wilson, E ∙ et al., the Guideline Development Group of the National Institute for Health and Care Excellence
Assessment and management of bipolar disorder: summary of updated NICE guidance
BMJ. 2014; 349, g5673
79.
Yatham, LN ∙ Kennedy, SH ∙ Parikh, SV ∙ et al.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Bipolar Disord. 2018; 20:97-170
80.
Oud, M ∙ Mayo-Wilson, E ∙ Braidwood, R ∙ et al.
Psychological interventions for adults with bipolar disorder: systematic review and meta-analysis
Br J Psychiatry. 2016; 208:213-222
81.
Miklowitz, DJ ∙ Efthimiou, O ∙ Furukawa, TA ∙ et al.
Adjunctive psychotherapy for bipolar disorder: a systematic review and component network meta-analysis
JAMA Psychiatry. 2021; 78:141-150
82.
Novick, DM ∙ Swartz, HA
Evidence-based psychotherapies for bipolar disorder
Focus Am Psychiatr Publ. 2019; 17:238-248
83.
Kato, T ∙ Ogasawara, K ∙ Motomura, K ∙ et al.
Practice guidelines for bipolar disorder by the JSMD (Japanese Society of Mood Disorders)
Psychiatry Clin Neurosci. 2024; 78:633-645
84.
Eisner, E ∙ Faulkner, S ∙ Allan, S ∙ et al.
Barriers and facilitators of user engagement with digital mental health interventions for people with psychosis or bipolar disorder: systematic review and best-fit framework synthesis
JMIR Ment Health. 2025; 12, e65246
85.
Morton, E ∙ Nicholas, J ∙ Yang, L ∙ et al.
Evaluating the quality, safety, and functionality of commonly used smartphone apps for bipolar disorder mood and sleep self-management
Int J Bipolar Disord. 2022; 10:10
86.
Gliddon, E ∙ Barnes, SJ ∙ Murray, G ∙ et al.
Online and mobile technologies for self-management in bipolar disorder: a systematic review
Psychiatr Rehabil J. 2017; 40:309-319
87.
Hirakawa, H ∙ Terao, T ∙ Muronaga, M ∙ et al.
Adjunctive bright light therapy for treating bipolar depression: a systematic review and meta-analysis of randomized controlled trials
Brain Behav. 2020; 10, e01876
88.
Sit, DK ∙ McGowan, J ∙ Wiltrout, C ∙ et al.
Adjunctive bright light therapy for bipolar depression: a randomized double-blind placebo-controlled trial
Am J Psychiatry. 2018; 175:131-139
89.
Fregna, L ∙ Attanasio, F ∙ Colombo, C
The effect of bright light therapy on irritability in bipolar depression: a single-blind randomised control trial
Int J Psychiatry Clin Pract. 2023; 27:416-418
90.
Singh, B ∙ Kung, S ∙ Poppe, KA ∙ et al.
Partial wake therapy and luminotherapy as an adjunct to usual care in hospitalized patients with depression - a pilot study
Psychiatry Res. 2024; 337, 115921
91.
Hester, L ∙ Dang, D ∙ Barker, CJ ∙ et al.
Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review
Chronobiol Int. 2021; 38:1375-1383
92.
Simjanoski, M ∙ Patel, S ∙ Boni, R ∙ et al.
Lifestyle interventions for bipolar disorders: a systematic review and meta-analysis
Neurosci Biobehav Rev. 2023; 152, 105257
93.
Kim, JA ∙ Sankar, A ∙ Marks, R ∙ et al.
Chronotherapeutic intervention targeting emotion regulation brain circuitry, symptoms, and suicide risk in adolescents and young adults with bipolar disorder: a pilot randomised trial
BMJ Ment Health. 2025; 28, e301338
94.
Swartz, HA
The social rhythm therapy workbook for bipolar disorder: stabilize your circadian rhythms to reduce stress, manage moods, and prevent future episodes
New Harbinger Publications, 2024
95.
Elsayed, OH ∙ Ercis, M ∙ Pahwa, M ∙ et al.
Treatment-resistant bipolar depression: therapeutic trends, challenges and future directions
Neuropsychiatr Dis Treat. 2022; 18:2927-2943
96.
Schoeyen, HK ∙ Kessler, U ∙ Andreassen, OA ∙ et al.
Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment
Am J Psychiatry. 2015; 172:41-51
97.
Zhang, J ∙ Wang, G ∙ Yang, X ∙ et al.
Efficacy and safety of electroconvulsive therapy plus medication versus medication alone in acute mania: a meta-analysis of randomized controlled trials
Psychiatry Res. 2021; 302, 114019
98.
Popiolek, K ∙ Bejerot, S ∙ Brus, O ∙ et al.
Electroconvulsive therapy in bipolar depression - effectiveness and prognostic factors
Acta Psychiatr Scand. 2019; 140:196-204
99.
Popiolek, K ∙ Bejerot, S ∙ Landén, M ∙ et al.
Association of clinical and demographic characteristics with response to electroconvulsive therapy in mania
JAMA Netw Open. 2022; 5, e2218330
100.
Loef, D ∙ Hoogendoorn, AW ∙ Somers, M ∙ et al.
A prediction model for electroconvulsive therapy effectiveness in patients with major depressive disorder from the Dutch ECT Consortium (DEC)
Mol Psychiatry. 2025; 30:1915-1924
101.
Kishi, T ∙ Sakuma, K ∙ Matsuda, Y ∙ et al.
Repetitive transcranial magnetic stimulation for mania: a systematic review and meta-analysis
Bipolar Disord. 2023; 25:160-161
102.
Konstantinou, G ∙ Hui, J ∙ Ortiz, A ∙ et al.
Repetitive transcranial magnetic stimulation (rTMS) in bipolar disorder: a systematic review
Bipolar Disord. 2022; 24:10-26
103.
McGirr, A ∙ Karmani, S ∙ Arsappa, R ∙ et al.
Clinical efficacy and safety of repetitive transcranial magnetic stimulation in acute bipolar depression
World Psychiatry. 2016; 15:85-86
104.
Biazus, TB ∙ Beraldi, GH ∙ Tokeshi, L ∙ et al.
All-cause and cause-specific mortality among people with bipolar disorder: a large-scale systematic review and meta-analysis
Mol Psychiatry. 2023; 28:2508-2524
105.
O'Connor, RC ∙ Worthman, CM ∙ Abanga, M ∙ et al.
Gone too soon: priorities for action to prevent premature mortality associated with mental illness and mental distress
Lancet Psychiatry. 2023; 10:452-464
106.
Belsher, BE ∙ Smolenski, DJ ∙ Pruitt, LD ∙ et al.
Prediction models for suicide attempts and deaths: a systematic review and simulation
JAMA Psychiatry. 2019; 76:642-651
107.
Clements, C ∙ Morriss, R ∙ Jones, S ∙ et al.
Suicide in bipolar disorder in a national English sample, 1996-2009: frequency, trends and characteristics
Psychol Med. 2013; 43:2593-2602
108.
Schaffer, A ∙ Malhi, GS
A new model for the prevention of suicide in bipolar disorder: every patient, every setting, every provider
Bipolar Disord. 2024; 26:309-312
109.
Del Matto, L ∙ Muscas, M ∙ Murru, A ∙ et al.
Lithium and suicide prevention in mood disorders and in the general population: a systematic review
Neurosci Biobehav Rev. 2020; 116:142-153
110.
Izadi, N ∙ Mitchell, RHB ∙ Giacobbe, P ∙ et al.
Suicide assessment and prevention in bipolar disorder: how current evidence can inform clinical practice
Focus Am Psychiatr Publ. 2023; 21:380-388
111.
Chung, TH ∙ Hanley, K ∙ Le, YC ∙ et al.
A validation study of PHQ-9 suicide item with the Columbia Suicide Severity Rating Scale in outpatients with mood disorders at National Network of Depression Centers
J Affect Disord. 2023; 320:590-594
112.
Stanley, B ∙ Brown, GK ∙ Brenner, LA ∙ et al.
Comparison of the safety planning intervention with follow-up vs usual care of suicidal patients treated in the emergency department
JAMA Psychiatry. 2018; 75:894-900
113.
Skopp, NA ∙ Smolenski, DJ ∙ Bush, NE ∙ et al.
Caring contacts for suicide prevention: a systematic review and meta-analysis
Psychol Serv. 2023; 20:74-83
114.
Chaudhary, AMD ∙ Memon, RI ∙ Dar, SK ∙ et al.
Suicide during transition of care: a review of targeted interventions
Psychiatr Q. 2020; 91:417-450
115.
WHO
LIVE LIFE: an implementation guide for suicide prevention in countries
World Health Organization, Geneva, 2021
116.
Shitomi-Jones, LM ∙ Dolman, C ∙ Jones, I ∙ et al.
Exploration of first onsets of mania, schizophrenia spectrum disorders and major depressive disorder in perimenopause
Nat Ment Health. 2024; 2:1161-1168
117.
Truong, D ∙ Marsh, W
Bipolar disorder in the menopausal transition
Curr Psychiatry Rep. 2019; 21:130
118.
Sharma, V ∙ Wood, KN ∙ Weaver, B ∙ et al.
Occurrence of postpartum manic or mixed episodes in women with bipolar I disorder: a systematic review and meta-analysis
Bipolar Disord. 2024; 26:240-248
119.
Vigod, SN ∙ Frey, BN ∙ Clark, CT ∙ et al.
Canadian Network for Mood and Anxiety Treatments 2024 clinical practice guideline for the management of perinatal mood, anxiety, and related disorders: guide de pratique 2024 du Canadian Network for Mood and Anxiety Treatments pour le traitement des troubles de l'humeur, des troubles anxieux et des troubles connexes périnatals
Can J Psychiatry. 2025;
published online Feb 12. https://doi.org/10.1177/07067437241303031
120.
Nicoloro-SantaBarbara, J ∙ Majd, M ∙ Miskowiak, K ∙ et al.
Cognition in bipolar disorder: an update for clinicians
Focus Am Psychiatr Publ. 2023; 21:363-369
121.
Miskowiak, KW ∙ Seeberg, I ∙ Jensen, MB ∙ et al.
Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: a systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force
Bipolar Disord. 2022; 24:354-374
122.
Bora, E
A meta-analysis of data-driven cognitive subgroups in bipolar disorder
Eur Neuropsychopharmacol. 2025; 90:48-57
123.
Green, MJ ∙ Girshkin, L ∙ Kremerskothen, K ∙ et al.
A systematic review of studies reporting data-driven cognitive subtypes across the psychosis spectrum
Neuropsychol Rev. 2020; 30:446-460
124.
Miskowiak, KW ∙ Seeberg, I ∙ Kjaerstad, HL ∙ et al.
Affective cognition in bipolar disorder: a systematic review by the ISBD targeting cognition task force
Bipolar Disord. 2019; 21:686-719
125.
Kanady, JC ∙ Soehner, AM ∙ Klein, AB ∙ et al.
The association between insomnia-related sleep disruptions and cognitive dysfunction during the inter-episode phase of bipolar disorder
J Psychiatr Res. 2017; 88:80-88
126.
Gogia, M ∙ Shah, AQ ∙ Kapczinski, F ∙ et al.
The impact of substance use disorder comorbidity on cognition of individuals with bipolar disorder: a systematic review
Psychiatry Res. 2022; 311, 114525
127.
Mario, A ∙ Ivana, L ∙ Anita, M ∙ et al.
Inflammatory biomarkers, cognitive functioning, and brain imaging abnormalities in bipolar disorder: a systematic review
Clin Neuropsychiatry. 2024; 21:32-62
128.
Millett, CE ∙ Perez-Rodriguez, M ∙ Shanahan, M ∙ et al.
C-reactive protein is associated with cognitive performance in a large cohort of euthymic patients with bipolar disorder
Mol Psychiatry. 2021; 26:4096-4105
129.
Van Rheenen, TE ∙ Lewandowski, KE ∙ Bauer, IE ∙ et al.
Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: an overview of evidence
Bipolar Disord. 2020; 22:13-27
130.
Samamé, C ∙ Durante, P ∙ Cattaneo, B ∙ et al.
Efficacy of cognitive remediation in bipolar disorder: systematic review and meta-analysis of randomized controlled trials
Psychol Med. 2023; 53:5361-5373
131.
Camprodon-Boadas, P ∙ De Prisco, M ∙ Rabelo-da-Ponte, FD ∙ et al.
Cognitive reserve and cognition in mood disorders: a systematic review and meta-analysis
Psychiatry Res. 2024; 339, 116083
132.
Dols, A ∙ Kessing, LV ∙ Strejilevich, SA ∙ et al.
Do current national and international guidelines have specific recommendations for older adults with bipolar disorder? A brief report
Int J Geriatr Psychiatry. 2016; 31:1295-1300
133.
Schouws, SN ∙ Comijs, HC ∙ Dols, A ∙ et al.
Five-year follow-up of cognitive impairment in older adults with bipolar disorder
Bipolar Disord. 2016; 18:148-154
134.
Diniz, BS ∙ Teixeira, AL ∙ Cao, F ∙ et al.
History of bipolar disorder and the risk of dementia: a systematic review and meta-analysis
Am J Geriatr Psychiatry. 2017; 25:357-362
135.
van Liempt, S ∙ Dols, A ∙ Schouws, S ∙ et al.
Comparison of social functioning in community-living older individuals with schizophrenia and bipolar disorder: a catchment area-based study
Int J Geriatr Psychiatry. 2017; 32:532-538
136.
Sinha, A ∙ Shariq, A ∙ Said, K ∙ et al.
Medical comorbidities in bipolar disorder
Curr Psychiatry Rep. 2018; 20:36
137.
Lala, SV ∙ Sajatovic, M
Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review
J Geriatr Psychiatry Neurol. 2012; 25:20-25
138.
Lambert, AM ∙ Parretti, HM ∙ Pearce, E ∙ et al.
Temporal trends in associations between severe mental illness and risk of cardiovascular disease: a systematic review and meta-analysis
PLoS Med. 2022; 19, e1003960
139.
Hayes, JF ∙ Miles, J ∙ Walters, K ∙ et al.
A systematic review and meta-analysis of premature mortality in bipolar affective disorder
Acta Psychiatr Scand. 2015; 131:417-425
140.
Teixeira, AL ∙ Almeida, OP ∙ Lavin, P ∙ et al.
Physical comorbidities of older age bipolar disorder (OABD) patients: a global replication analysis of prevalence and sex differences
Gen Hosp Psychiatry. 2024; 90:6-11
141.
Almeida, OP ∙ Dols, A ∙ Blanken, MAJT ∙ et al.
Physical health burden among older men and women with bipolar disorder: results from the GAGE-BD collaboration
Am J Geriatr Psychiatry. 2022; 30:727-732
142.
Blanken, MAJT ∙ Oudega, ML ∙ Almeida, OP ∙ et al.
Sex differences among older adults with bipolar disorder: results from the Global Aging & Geriatric Experiments in Bipolar Disorder (GAGE-BD) project
Am J Geriatr Psychiatry. 2024; 32:326-338
143.
Sajatovic, M ∙ Rej, S ∙ Almeida, OP ∙ et al.
Bipolar symptoms, somatic burden and functioning in older-age bipolar disorder: a replication study from the Global Aging & Geriatric Experiments in Bipolar Disorder database (GAGE-BD) project
Int J Geriatr Psychiatry. 2024; 39, e6057
144.
Montejo, L ∙ Torrent, C ∙ Jiménez, E ∙ et al.
Cognition in older adults with bipolar disorder: an ISBD task force systematic review and meta-analysis based on a comprehensive neuropsychological assessment
Bipolar Disord. 2022; 24:115-136
145.
Orhan, M ∙ Schouws, S ∙ van Oppen, P ∙ et al.
Cognitive functioning in late life affective disorders: comparing older adults with bipolar disorder, late life depression and healthy controls
J Affect Disord. 2023; 320:468-473
146.
Beunders, AJM ∙ Kemp, T ∙ Korten, NCM ∙ et al.
Cognitive performance in older-age bipolar disorder: investigating psychiatric characteristics, cardiovascular burden and psychotropic medication
Acta Psychiatr Scand. 2021; 144:392-406
147.
Ehrlich, TJ ∙ Ryan, KA ∙ Burdick, KE ∙ et al.
Cognitive subgroups and their longitudinal trajectories in bipolar disorder
Acta Psychiatr Scand. 2022; 146:240-250
148.
Burdick, KE ∙ Russo, M ∙ Frangou, S ∙ et al.
Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications
Psychol Med. 2014; 44:3083-3096
149.
Regier, DA ∙ Farmer, ME ∙ Rae, DS ∙ et al.
Comorbidity of mental disorders with alcohol and other drug abuse. results from the Epidemiologic Catchment Area (ECA) study
JAMA. 1990; 264:2511-2518
150.
Hunt, GE ∙ Malhi, GS ∙ Cleary, M ∙ et al.
Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990-2015: systematic review and meta-analysis
J Affect Disord. 2016; 206:331-349
151.
Bahji, A ∙ Danilewitz, M ∙ Vazquez, G ∙ et al.
The prevalence of cannabis use disorder comorbidity in individuals with bipolar disorder: a systematic review and meta-analysis
Can J Addict. 2021; 12:22-38
152.
Lasagna, CA ∙ Pleskac, TJ ∙ Burton, CZ ∙ et al.
Mathematical modeling of risk-taking in bipolar disorder: evidence of reduced behavioral consistency, with altered loss aversion specific to those with history of substance use disorder
Comput Psychiatr. 2022; 6:96-116
153.
Swann, AC
The strong relationship between bipolar and substance-use disorder
Ann N Y Acad Sci. 2010; 1187:276-293
154.
Bart, CP ∙ Titone, MK ∙ Ng, TH ∙ et al.
Neural reward circuit dysfunction as a risk factor for bipolar spectrum disorders and substance use disorders: a review and integration
Clin Psychol Rev. 2021; 87, 102035
155.
Sperry, SH ∙ Stromberg, AR ∙ Murphy, VA ∙ et al.
Longitudinal interplay between alcohol use, mood, and functioning in bipolar spectrum disorders
JAMA Netw Open. 2024; 7, e2415295
156.
Mueser, KT ∙ Glynn, SM ∙ Cather, C ∙ et al.
A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders
Schizophr Bull. 2013; 39:658-672
157.
Gordon-Smith, K ∙ Lewis, KJS ∙ Vallejo Auñón, FM ∙ et al.
Patterns and clinical correlates of lifetime alcohol consumption in women and men with bipolar disorder: findings from the UK Bipolar Disorder Research Network
Bipolar Disord. 2020; 22:731-738
158.
Beaulieu, S ∙ Saury, S ∙ Sareen, J ∙ et al.
The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders
Ann Clin Psychiatry. 2012; 24:38-55
159.
Salloum, IM ∙ Cornelius, JR ∙ Daley, DC ∙ et al.
Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study
Arch Gen Psychiatry. 2005; 62:37-45
160.
Morton, E ∙ Foxworth, P ∙ Dardess, P ∙ et al.
“Supporting Wellness”: a depression and bipolar support alliance mixed-methods investigation of lived experience perspectives and priorities for mood disorder treatment
J Affect Disord. 2022; 299:575-584
161.
Jagfeld, G ∙ Lobban, F ∙ Marshall, P ∙ et al.
Personal recovery in bipolar disorder: systematic review and “best fit” framework synthesis of qualitative evidence—a POETIC adaptation of CHIME
J Affect Disord. 2021; 292:375-385
162.
Kelly, JF ∙ Hoffman, L ∙ Vilsaint, C ∙ et al.
Peer support for mood disorder: characteristics and benefits from attending the Depression and Bipolar Support Alliance mutual-help organization
J Affect Disord. 2019; 255:127-135
163.
Murray, G ∙ Suto, M ∙ Hole, R ∙ et al.
Self-management strategies used by ‘high functioning’ individuals with bipolar disorder: from research to clinical practice
Clin Psychol Psychother. 2011; 18:95-109
164.
Perich, T ∙ Mitchell, PB ∙ Vilus, B
Stigma in bipolar disorder: a current review of the literature
Aust N Z J Psychiatry. 2022; 56:1060-1064
165.
Ellouze, S ∙ Jenhani, R ∙ Bougacha, D ∙ et al.
[Self-stigma and functioning in patients with bipolar disorder]
Encephale. 2023; 49:34-40
166.
Gilkes, MJ ∙ Perich, T ∙ Meade, T
Predictors of self-stigma in bipolar disorder: depression, mania, and perceived cognitive function
Stigma Health. 2019; 4:330-336
167.
Post, F ∙ Pardeller, S ∙ Frajo-Apor, B ∙ et al.
Quality of life in stabilized outpatients with bipolar I disorder: associations with resilience, internalized stigma, and residual symptoms
J Affect Disord. 2018; 238:399-404
168.
Hidalgo-Mazzei, D ∙ Berk, M ∙ Cipriani, A ∙ et al.
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition
Br J Psychiatry. 2019; 214:27-35
169.
Zengin, G ∙ Topak, OZ ∙ Atesci, O ∙ et al.
The efficacy and safety of transcranial magnetic stimulation in treatment-resistant bipolar depression
Psychiatr Danub. 2022; 34:236-244
170.
Hsu, CW ∙ Chou, PH ∙ Brunoni, AR ∙ et al.
Comparing different non-invasive brain stimulation interventions for bipolar depression treatment: a network meta-analysis of randomized controlled trials
Neurosci Biobehav Rev. 2024; 156, 105483
171.
Raj, KS ∙ Geoly, AD ∙ Veerapal, C ∙ et al.
Pilot study of stanford neuromodulation therapy (SNT) for bipolar depression
Brain Stimul. 2024; 17:321-323
172.
Li, K ∙ Bichlmeier, A ∙ DuPont, C ∙ et al.
Fast depressive symptoms improvement in bipolar I disorder after Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT): a two-site feasibility and safety open-label trial
J Affect Disord. 2024; 365:359-363
173.
Nunez, NA ∙ Joseph, B ∙ Kumar, R ∙ et al.
An update on the efficacy of single and serial intravenous ketamine infusions and esketamine for bipolar depression: a systematic review and meta-analysis
Brain Sci. 2023; 13, 1672
174.
Singh, B ∙ Vande Voort, JL ∙ Frye, MA ∙ et al.
Can ketamine be a safe option for treatment-resistant bipolar depression?
Expert Opin Drug Saf. 2022; 21:717-720
175.
Aaronson, ST ∙ van der Vaart, A ∙ Miller, T ∙ et al.
Single-dose synthetic psilocybin with psychotherapy for treatment-resistant bipolar type II major depressive episodes: a nonrandomized open-label trial
JAMA Psychiatry. 2024; 81:555-562
176.
Fried, EI ∙ Cristea, IA ∙ Naudet, F
Treating bipolar depression using psilocybin-validity threats regarding efficacy and safety
JAMA Psychiatry. 2024; 81:633-634
Figure 1 Secondary causes of bipolar disorders
Figure 2 Pharmacotherapeutic treatments for bipolar disorder
Dexmedetomidine (sublingual) and loxapine (inhaled) are used for the rapid treatment of agitation. SSRI=selective serotonin reuptake inhibitor. *Used as an adjunct with a mood stabiliser (second-line agent).
Figure 3 Bipolar-specific therapeutic strategies
Supplementary appendix
